drugset / Trial / NCT06471257
A Study to Investigate Efficacy and Safety of PT027 Compared With PT007 in Symptomatic Chinese Adults With Asthma
RandomizedParallel-groupDouble-blindTreatment
Summary
An event-driven, Phase III study to evaluate the efficacy and safety of BDA MDI compared with AS MDI in reducing the risk of a severe asthma exacerbation in symptomatic Chinese adults with asthma.
Timeline
- Start
- 2024-06-17
- Primary completion
- 2027-10-04
- Completion
- 2027-10-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Budesonide | Small molecule | 160 ug | Inhaled |
| Comparator | Salbutamol | Unknown | 180 ug | Inhaled |